Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1942-1961
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Table 2 Molecular docking binding energy
| Molecule Name | Binding energy (kcal/mol) | |||||
| TP53 | AKT1 | Jun | Caspase-3 | MAPK3 | MAPK1 | |
| Quercetin | -7.3 | -6.4 | -7.9 | -7.9 | -7.3 | -6.4 |
| Kaempferol | -7.1 | -6.3 | -7.9 | -8.1 | -7.1 | -6.3 |
| Beta-sitosterol | -7.6 | -6.1 | -7.3 | -8.7 | -7.6 | -6.1 |
| Luteolin | -7.2 | -6.5 | -8.6 | -8.2 | -7.2 | -6.5 |
| Stigmasterol | -7 | -6.9 | -7.6 | -7 | -7 | -6.9 |
- Citation: Yang YF, Yuan L, Li XY, Liu Q, Jiang WJ, Jiao TQ, Li JQ, Ye MY, Niu Y, Nan Y. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World J Diabetes 2024; 15(9): 1942-1961
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1942.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1942